DI Mobile Menu

Search form


Nuclear Imaging

Nuclear Imaging

Clinicians at Mount Sinai in New York are the first in the state to use a recently FDA-approved PET technique with florbetapir to detect Alzheimer’s disease.

PET imaging has demonstrated an unexpected link between low dopamine levels and aggression in young healthy adults.

New diagnostic agents for use with PET imaging are improving identification of beta-amyloid, the brain plaque associated with Alzheimer’s disease. But there are some concerns about training to accurately read these studies.

Osman Ratib, MD, PhD, FAHA, professor and chief of nuclear medicine in the Department of Radiology at the University Hospital of Geneva, discusses the advantages and future of the hybrid PET/MR modality.

As the devastation following the earthquake, tsunami, and nuclear disaster in Japan continue to unfold, radiologists in the U.S. are lending their expertise and assistance.

PET hybrid technologies are already hot, and two innovations discussed during the final session of ECR 2011 are aimed at making them more even powerful and efficient.

A molecular imaging technique may prove useful in early assessment of treatment response for cisplatin-resistant ovarian cancer, according to a study published in the Journal of Nuclear Medicine.


Subscribe to Nuclear Imaging on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.